Literature DB >> 23934091

A distinct subgroup of cardiomyopathy patients characterized by transcriptionally active cardiotropic erythrovirus and altered cardiac gene expression.

U Kuhl1, D Lassner, A Dorner, M Rohde, F Escher, B Seeberg, E Hertel, C Tschope, C Skurk, U M Gross, H-P Schultheiss, W Poller.   

Abstract

Recent studies have detected erythrovirus genomes in the hearts of cardiomyopathy and cardiac transplant patients. Assessment of the functional status of viruses may provide clinically important information beyond detection of the viral genomes. Here, we report transcriptional activation of cardiotropic erythrovirus to be associated with strongly altered myocardial gene expression in a distinct subgroup of cardiomyopathy patients. Endomyocardial biopsies (EMBs) from 415 consecutive cardiac erythrovirus (B19V)-positive patients with clinically suspected cardiomyopathy were screened for virus-encoded VP1/VP2 mRNA indicating transcriptional activation of the virus, and correlated with cardiac host gene expression patterns in transcriptionally active versus latent infections, and in virus-free control hearts. Transcriptional activity was detected in baseline biopsies of only 66/415 patients (15.9 %) harbouring erythrovirus. At the molecular level, significant differences between cardiac B19V-positive patients with transcriptionally active versus latent virus were revealed by expression profiling of EMBs. Importantly, latent B19V infection was indistinguishable from controls. Genes involved encode proteins of antiviral immune response, B19V receptor complex, and mitochondrial energy metabolism. Thus, functional mapping of erythrovirus allows definition of a subgroup of B19V-infected cardiomyopathy patients characterized by virus-encoded VP1/VP2 transcripts and anomalous host myocardial transcriptomes. Cardiac B19V reactivation from latency, as reported here for the first time, is a key factor required for erythrovirus to induce altered cardiac gene expression in a subgroup of cardiomyopathy patients. Virus genome detection is insufficient to assess pathogenic potential, but additional transcriptional mapping should be incorporated into future pathogenetic and therapeutic studies both in cardiology and transplantation medicine.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23934091     DOI: 10.1007/s00395-013-0372-y

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  22 in total

Review 1.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  Brazilian Society of Cardiology Guideline on Myocarditis - 2022.

Authors:  Marcelo Westerlund Montera; Fabiana G Marcondes-Braga; Marcus Vinícius Simões; Lídia Ana Zytynski Moura; Fabio Fernandes; Sandrigo Mangine; Amarino Carvalho de Oliveira Júnior; Aurea Lucia Alves de Azevedo Grippa de Souza; Bárbara Maria Ianni; Carlos Eduardo Rochitte; Claudio Tinoco Mesquita; Clerio F de Azevedo Filho; Dhayn Cassi de Almeida Freitas; Dirceu Thiago Pessoa de Melo; Edimar Alcides Bocchi; Estela Suzana Kleiman Horowitz; Evandro Tinoco Mesquita; Guilherme H Oliveira; Humberto Villacorta; João Manoel Rossi Neto; João Marcos Bemfica Barbosa; José Albuquerque de Figueiredo Neto; Louise Freire Luiz; Ludhmila Abrahão Hajjar; Luis Beck-da-Silva; Luiz Antonio de Almeida Campos; Luiz Cláudio Danzmann; Marcelo Imbroise Bittencourt; Marcelo Iorio Garcia; Monica Samuel Avila; Nadine Oliveira Clausell; Nilson Araujo de Oliveira; Odilson Marcos Silvestre; Olga Ferreira de Souza; Ricardo Mourilhe-Rocha; Roberto Kalil Filho; Sadeer G Al-Kindi; Salvador Rassi; Silvia Marinho Martins Alves; Silvia Moreira Ayub Ferreira; Stéphanie Itala Rizk; Tiago Azevedo Costa Mattos; Vitor Barzilai; Wolney de Andrade Martins; Heinz-Peter Schultheiss
Journal:  Arq Bras Cardiol       Date:  2022-07       Impact factor: 2.667

3.  Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-β treatment in patients with chronic viral cardiomyopathy.

Authors:  Heinz-Peter Schultheiss; Cornelia Piper; Olaf Sowade; Finn Waagstein; Joachim-Friedrich Kapp; Karl Wegscheider; Georg Groetzbach; Matthias Pauschinger; Felicitas Escher; Eloisa Arbustini; Harald Siedentop; Uwe Kuehl
Journal:  Clin Res Cardiol       Date:  2016-04-25       Impact factor: 5.460

4.  Absent MicroRNAs in Different Tissues of Patients with Acquired Cardiomyopathy.

Authors:  Christine S Siegismund; Maria Rohde; Uwe Kühl; Felicitas Escher; Heinz Peter Schultheiss; Dirk Lassner
Journal:  Genomics Proteomics Bioinformatics       Date:  2016-07-28       Impact factor: 7.691

Review 5.  Viral myocarditis: a prime example for endomyocardial biopsy-guided diagnosis and therapy.

Authors:  Sophie Van Linthout; Carsten Tschöpe
Journal:  Curr Opin Cardiol       Date:  2018-05       Impact factor: 2.161

Review 6.  Cardiovascular Involvement in Chronic Hepatitis C Virus Infections - Insight from Novel Antiviral Therapies.

Authors:  Wolfgang Poller; Arash Haghikia; Mario Kasner; Ziya Kaya; Udo Bavendiek; Heiner Wedemeier; Hans-Jörg Epple; Carsten Skurk; Ulf Landmesser
Journal:  J Clin Transl Hepatol       Date:  2018-01-26

7.  Telbivudine in chronic lymphocytic myocarditis and human parvovirus B19 transcriptional activity.

Authors:  Sophie Van Linthout; Ahmed Elsanhoury; Oliver Klein; Marzena Sosnowski; Kapka Miteva; Dirk Lassner; Mohamed Abou-El-Enein; Burkert Pieske; Uwe Kühl; Carsten Tschöpe
Journal:  ESC Heart Fail       Date:  2018-08-11

8.  Telbivudine Reduces Parvovirus B19-Induced Apoptosis in Circulating Angiogenic Cells.

Authors:  Thomas Zobel; C-Thomas Bock; Uwe Kühl; Maria Rohde; Dirk Lassner; Heinz-Peter Schultheiss; Caroline Schmidt-Lucke
Journal:  Viruses       Date:  2019-03-06       Impact factor: 5.048

Review 9.  Inflammatory Cardiomyopathy: A Current View on the Pathophysiology, Diagnosis, and Treatment.

Authors:  Jan Krejci; Dalibor Mlejnek; Dana Sochorova; Petr Nemec
Journal:  Biomed Res Int       Date:  2016-06-12       Impact factor: 3.411

10.  Therapeutic implications of a combined diagnostic workup including endomyocardial biopsy in an all-comer population of patients with heart failure: a retrospective analysis.

Authors:  Efthymios Sotiriou; Susanne Heiner; Thomas Jansen; Moritz Brandt; Kai Helge Schmidt; Karl-Friedrich Kreitner; Tilman Emrich; Heinz-Peter Schultheiss; Eberhard Schulz; Thomas Münzel; Philip Wenzel
Journal:  ESC Heart Fail       Date:  2018-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.